Christensen James's most recent trade in Boundless Bio Inc. was a trade of 16,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 23, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Boundless Bio Inc | James Christensen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2025 | 16,000 | 16,000 | - | - | Stock Option (right to buy) | |
| Boundless Bio Inc | James Christensen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Mar 2024 | 13,219 | 13,219 | - | - | Stock Option | |
| Mirati Therapeutics Inc | Christensen James | EVP & Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 57.50 per share. | 18 Dec 2023 | 2,387 | 141,645 (0%) | 0% | 57.5 | 137,253 | Common Stock |
| Mirati Therapeutics Inc | James Christensen | EVP & Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 37.00 per share. | 09 Aug 2023 | 22,297 | 146,420 (0%) | 0% | 37 | 824,989 | Common Stock |
| Mirati Therapeutics Inc | James Christensen | EVP & Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 45.29 per share. | 24 May 2023 | 619 | 124,123 (0%) | 0% | 45.3 | 28,035 | Common Stock |
| Mirati Therapeutics Inc | James Christensen | EVP, Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2023 | 45,456 | 45,456 | - | - | Employee Stock Option (Right to Buy) | |
| Mirati Therapeutics Inc | James Christensen | EVP, Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2023 | 26,864 | 124,742 (0%) | 0% | 0 | Common Stock | |
| Mirati Therapeutics Inc | James Christensen | EVP, Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 42.38 per share. | 17 Jan 2023 | 1,358 | 98,765 (0%) | 0% | 42.4 | 57,549 | Common Stock |
| Mirati Therapeutics Inc | James Christensen | EVP, Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 42.38 per share. | 17 Jan 2023 | 887 | 97,878 (0%) | 0% | 42.4 | 37,593 | Common Stock |
| Mirati Therapeutics Inc | James Christensen | EVP, Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 46.60 per share. | 04 Jan 2023 | 1,949 | 100,123 (0%) | 0% | 46.6 | 90,823 | Common Stock |
| Mirati Therapeutics Inc | James Christensen | EVP, Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 43.00 per share. | 16 Dec 2022 | 2,410 | 102,072 (0%) | 0% | 43.0 | 103,624 | Common Stock |
| Mirati Therapeutics Inc | James Christensen | EVP, Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 90.19 per share. | 02 Dec 2022 | 1,726 | 104,482 (0%) | 0% | 90.2 | 155,667 | Common Stock |
| Mirati Therapeutics Inc | James Christensen | EVP, Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Sep 2022 | 19,149 | 106,089 (0%) | 0% | 0 | Common Stock | |
| Mirati Therapeutics Inc | James Christensen | EVP, Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 63.54 per share. | 23 May 2022 | 624 | 86,804 (0%) | 0% | 63.5 | 39,649 | Common Stock |
| Mirati Therapeutics Inc | James Christensen | EVP, Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2022 | 17,821 | 17,821 | - | - | Employee Stock Option (Right to Buy) | |
| Mirati Therapeutics Inc | James Christensen | EVP, Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2022 | 10,755 | 88,055 (0%) | 0% | 0 | Common Stock | |
| Mirati Therapeutics Inc | James Christensen | EVP, Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 120.51 per share. | 14 Jan 2022 | 627 | 87,428 (0%) | 0% | 120.5 | 75,558 | Common Stock |
| Mirati Therapeutics Inc | James Christensen | EVP, Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 147.72 per share. | 04 Jan 2022 | 1,442 | 77,300 (0%) | 0% | 147.7 | 213,017 | Common Stock |
| Mirati Therapeutics Inc | James Christensen | EVP, Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 154.34 per share. | 24 May 2021 | 435 | 53,850 (0%) | 0% | 154.3 | 67,138 | Common Stock |